Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Shu Yang IVIG evaluating efficacy, safety, and pharmacokinetics in primary immunodeficiency disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency Disease

Drugs mentioned

• Shu Yang IVIG

Snippet

Sponsor: Azidus Brasil | Conditions: Primary Immunodeficiency Disease | Phase 3 | Status: UNKNOWN